ResearcherDalian Medical UniversityActive in the last 2 years
Yalan Luo
Matched on ORCID iD 0000-0002-9619-5468; OpenAlex author ID A5055940272. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 6
2021: 1 paper · 2022: none · 2023: none · 2024: 2 papers · 2025: 1 paper
Papers 4
- Progression from chronic pancreatitis to pancreatic cancer: the potential involvement of gut microbiota. Co-author DOI 10.1016/j.pan.2025.04.014↗
- Busting myths, biting facts: Unraveling the link between Porphyromonas and pancreatic cancer risk. Co-author DOI 10.1016/j.phrs.2024.107325↗
- Occupational exposure to diesel exhausts and pancreatic cancer. First author DOI 10.1097/js9.0000000000001498↗
- Application of Mass Spectrometry in Pancreatic Cancer Translational Research. First author DOI 10.3389/fonc.2021.667427↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Hailong Chen · 3 shared papers, 2021–2024 · strength 0.81
- Paper Occupational exposure to diesel exhausts and pancreatic cancer. DOI 10.1097/js9.0000000000001498↗
- Paper Busting myths, biting facts: Unraveling the link between Porphyromonas and pancreatic cancer risk. DOI 10.1016/j.phrs.2024.107325↗
- Paper Application of Mass Spectrometry in Pancreatic Cancer Translational Research. DOI 10.3389/fonc.2021.667427↗
- Peng Ge · 3 shared papers, 2021–2024 · strength 0.81
- Paper Occupational exposure to diesel exhausts and pancreatic cancer. DOI 10.1097/js9.0000000000001498↗
- Paper Busting myths, biting facts: Unraveling the link between Porphyromonas and pancreatic cancer risk. DOI 10.1016/j.phrs.2024.107325↗
- Paper Application of Mass Spectrometry in Pancreatic Cancer Translational Research. DOI 10.3389/fonc.2021.667427↗
- Hailong Chen · 1 shared paper, 2025 · strength 0.37
- Jie Liu · 1 shared paper, 2025 · strength 0.37
- Caiming Xu · 1 shared paper, 2021 · strength 0.13
- Guixin Zhang · 1 shared paper, 2021 · strength 0.13
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.